Kymera Therapeutics, Inc.
KYMR
Revenue
3.74M
▼-21.91M▼-85.42%
3 Months ChangeAssets
1.03B
▲208.82M▲25.28%
3 Months ChangeLiabilities
141.91M
▲815.00k▲0.5776%
3 Months ChangeFree Cash Flow
-46.99M
▲984.00k▲2.05%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-31
Form 10-Q
ID: 0000950170-24-119249
2024-10-31
Form 8-K
ID: 0000950170-24-119245
2024-08-20
Form 8-K
ID: 0001193125-24-203755
2024-08-07
Form 10-Q
ID: 0000950170-24-092275
2024-08-07
Form 8-K
ID: 0000950170-24-092272
2024-07-08
Form 8-K
ID: 0001193125-24-176312
2024-06-20
Form 8-K
ID: 0001193125-24-164550
2024-05-02
Form 10-Q
ID: 0000950170-24-051567
2024-05-02
Form 8-K
ID: 0000950170-24-051566
2024-04-01
Form 8-K
ID: 0001193125-24-082641